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FRETCationic liposomes have been proposed as biocompatible gene delivery vectors, able to overcome the barriers
imposed by cell membranes. Besides lipids, other surfactant molecules have been successfully used in the
composition of gene carriers. In the present work, we used a Gemini surfactant, represented by the general
structure [C14H29(CH3)2N+(CH2)2N+(CH3)2C14H29]2Br− and herein designated 14–2–14, to prepare cationic
gene carriers, both as the sole component and in combination with neutral helper lipids, cholesterol and
DOPE. The effectiveness of three Gemini-based formulations, namely neat 14–2–14, 14–2–14:Chol (1:1 molar
ratio) and 14–2–14:Chol:DOPE (2:1:1 molar ratio), to mediate gene delivery was evaluated in DNA mixtures
of +/− charge ratios ranging from 1/1 to 12/1. After ruling out cytotoxicity as responsible for the differences
observed in the transfection competence, structural and physical properties of the vector were investigated,
using several techniques. The size and surface charge density (zeta potential) of surfactant-based structures
were determined by conventional techniques and the thermotropic behaviour of aqueous dispersions of
surfactant/lipid/DNA formulations was monitored by ﬂuorescence polarization of DPH and DPH-PA probes.
The capacity of lipoplexes to interact with membrane-mimicking lipid bilayers was evaluated, using the
PicoGreen assay and a FRET technique. Our data indicate inefﬁciency of the neat 14–2–14 formulation for gene
delivery, which could result from the large dimensions of the particles and/or from its relative incompetence
to release DNA upon interaction with anionic lipids. The addition of cholesterol or cholesterol and DOPE
conferred to Gemini-based gene carrier transfection activity at speciﬁc ranges of +/− charge ratios.
Fluorescence polarization data suggest that an order parameter within a speciﬁc range was apparently needed
for complexes to displaymaximal transfection efﬁciency. The transfection-competent formulations showed to
be efﬁciently destabilized by interaction with different anionic and zwitterionic bilayers, including those
containing PS and cardiolipin. These data are discussed in terms of the potential of these formulations to
address different intracellular targets.ine; DOPC, dioleoylphosphati-
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Ever since Felgner and co-workers [1] found that cationic lipids
have a strong potential to mediate intracellular delivery of geneticmaterial, the development of new lipid-like molecules has become
one of the main goals of lipid-based technologies. Lipoplexes, i.e.
complexes composed of cationic lipid-based nanostructures and DNA,
have been developed as vehicles to deliver DNA into cells of different
tissues, providing the possibility to reach speciﬁc target cells and to
overcome enzymatic degradation, and cell and nuclear membrane
barriers [2,3].
Cationic lipid-like amphiphiles not only package DNA, thereby
protecting it from DNAase degradation, but also mediate the
translocation across negatively charged membrane barriers, in order
to guarantee the delivery of the gene cargo into the nucleus [4] or
mitochondria [5].
Although the molecular details on the mechanism by which cells
internalize particles are still poorly understood, the current evidence
supports the hypothesis that cationic amphiphile-based vectors enter
cells through the endocytic pathway [4]. In this regard, the endosome
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have the ability to promote release of the carried DNA into the cytosol,
eventually leading to nuclear translocation [6]. On the other hand, if
the mitochondria are the target, successful gene delivery requires
carrier interaction with speciﬁc mitochondrial lipids, such as
cardiolipin [5].
To improve the properties needed for efﬁcient gene delivery and
expression, additional lipid components (helper lipids), such as 1,2-
dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) and cholesterol,
have been included in the Gemini formulations [7–9]. These helper
componentsmay favour the formation of an inverted hexagonal phase
(HII) under physiologically relevant conditions [7,9], an event that has
been referred to promote membrane fusion [10]. Besides having the
propensity to be incorporated in structures of high negative curvature,
cholesterol has been shown to enhance the stiffness of cationic lipid
bilayers, since it increases lipid order and minimises thermotropic
phase transitions [11]. This effect seems also to improve the
transfection efﬁciency, by mechanisms probably independent of the
ability to release DNA from the complexes [8]. The capacity of
cholesterol for stabilizing a lamellar ﬂuid, yet ordered, phase – liquid-
ordered phase, Lo [12] – may lead to a lipid/DNA arrangement that
combines stability with plasticity, two essential features of an efﬁcient
gene delivery system.
Gemini surfactants have been used as a cationic component of
gene carriers [13], having the advantage of being easily prepared and
offering a wide range of possibilities for structure modulation [14–
16]. This feature allows the design of Gemini surfactants showing low
toxicity, very low immunogenicity, high stability in biological ﬂuids
and biodegrability, which are essential requirements for a gene
delivery system [13]. These surfactants are composed of a long
hydrocarbon chain, an ionic group, a spacer, another ionic group and
another long hydrocarbon chain, in sequence [15]. Due to the
presence of a multivalent positively charged polar group [14,16],
Gemini surfactants may efﬁciently compact the negatively charged
molecule of DNA, allowing the formation of a particle small enough to
be endocytosed by the cell [13]. Other Gemini surfactant features,
such as the conformational ﬂexibility provided by the spacer [17] and
the double hydrocarbon chains [16], have been related with the
ability of Gemini-based systems to mediate transfection. Gemini
surfactants with propensity to form vesicle structures have revealed
advantages in terms of transfection activity, when compared to those
forming micelles, the former excluding the need of helper lipid
addition [16]. The alkanediyl-α,ω-bis(alkyldimethylammonium bro-
mide) dimeric surfactant family has been one of the most
investigated with respect to its physicochemical properties [14,16]
and several elements of this family have been reported as efﬁcient
transfection agents [13].
In this work, we used the Gemini surfactant dimethylene-1,2-bis
(tetradecyldimethylammonium bromide) or [C14H29(CH3)2N+
(CH2)2N+(CH3)2C14H29]2Br−, with 14 carbon atoms in the hydro-
carbon chains and 2 carbon atoms in the spacer, referred to as 14–2–
14, alone or in combination with the helper lipids cholesterol and
DOPE, to compare the biophysical properties of transfecting and non-
transfecting formulations based on the same surfactant molecule. In
previous studies performed in our laboratory, this surfactant revealed
ability to mix with zwitterionic lipids forming liposomes, presenting
a phase transition that undergoes modulation by the other compo-
nents of the mixture, in a temperature range easily followed in
laboratory.
The aim of the present work is two-fold: ﬁrstly, to explore the
potential of the Gemini surfactant 14–2–14, combined or not with the
helper lipids cholesterol and DOPE, as an agent for transfection;
secondly, to establish a relationship between the biophysical
properties of surfactant/lipid-based DNA vectors and their efﬁciency
to promote gene expression, in order to contribute for the generation
of meaningful structure–activity relationships.2. Materials and methods
2.1. Cells
TSA cells (BALB/c female mouse mammary adenocarcinoma cell
line) were maintained at 37 °C, under 5% CO2, in Dulbecco's modiﬁed
Eagle's medium–high glucose (DMEM–HG; Sigma, St. Louis, MO),
supplemented with 10% (v/v) heat inactivated fetal bovine serum
(FBS; Sigma, St. Louis, MO), penicillin (100 U/ml) and streptomycin
(100 μg/ml). TSA cells grown in monolayer were detached by
treatment with 0.25% trypsin solution (Sigma, St. Louis, MO). For in
vitro transfection studies, 5×104 TSA cells were seeded in 1 ml of
medium in 48-well culture plates, 24 h before transfection, and used
at 50–70% conﬂuence.
2.2. Preparation of cationic liposomes and their complexes with DNA
Small unilamellar vesicles (SUV) were prepared either from
Gemini surfactant 14–2–14, surfactant plus cholesterol (1:1 mol
ratio), or surfactant plus cholesterol and DOPE (2:1:1 mol ratio), by
extrusion of multilamellar vesicles (MLV). Brieﬂy, DOPE (Avanti Polar
Lipids, Alabaster, AL) and/or cholesterol (Sigma, St. Louis, MO) and
Gemini (synthesized in the Chemistry Department, University of
Porto, according to an established procedure [15]) were dissolved in
CHCl3:CH3OH (1:1) and then mixed at the desired molar ratio and
dried under vacuum in a rotatory evaporator. The dried lipid ﬁlms
were hydrated with deionised water, unless stated otherwise, to a
ﬁnal lipid concentration of 2 mM. The resulting MLV were then
sonicated for 3 min and extruded 21 times through two stacked
polycarbonate ﬁlters of 50 nm pore diameter using a Liposofast device
(Avestin, Toronto, Canada). The resulting liposomes (SUV) were
subsequently diluted three times with deionised water and, for the
transfection studies, ﬁlter-sterilized utilizing 0.22 μm pore-diameter
ﬁlters (Schleicher & Schuell, BioScience, Germany). Lipoplexes were
prepared by sequentially mixing 100 μl of a HEPES-buffered saline
solution (HBS; 100 mMNaCl, 20 mMHEPES, pH 7.4) with a volume of
liposomes (dependent on the desired +/− lipid/DNA charge ratio)
and 100 μl of HBS solution containing 1 μg of pCMVluc encoding
luciferase (a gift fromDr. P. Felgner; Vical, San Diego, CA). Themixture
was further incubated for 15 min at room temperature. Lipoplexes
were used immediately after being prepared.
2.3. In vitro transfection activity
TSA cells were covered with 0.3 ml of DMEM–HG without serum
before lipid/DNA complexes were added. The complexes (containing
1 μg of DNA) were added gently to cells in a volume of 0.2 ml per well.
After 4 h incubation (in 5% CO2 at 37 °C) the medium was replaced
with DMEM–HG and the cells were further incubated for 48 h. The
cells were thenwashed twicewith phosphate-buffered saline solution
(PBS) and 100 μl of lysis buffer (1 mM DTT; 1 mM EDTA; 25 mM Tris-
phosphate, pH 7.8; 8 mM MgCl2; 15% glycerol; 1% v/v Triton X-100)
were added to each well. The level of gene expression in the lysates
was evaluated bymeasuring light production by luciferase in an LMax
II 384 luminometer (Molecular Devices, Union City, CA). The protein
content of the lysates was measured by the Dc Protein Assay reagent
(Bio-Rad, Hercules, CA) using bovine serum albumin as the standard.
The data were expressed as relative light units (RLU) of luciferase per
mg of total cell protein.
2.4. Cell viability
Cell viability was assessed by a modiﬁed Alamar Blue assay, as
previously described [18]. Brieﬂy, 0.4 ml of 10% (V/V) Alamar Blue dye
in complete DMEM–HG medium was added to each well, 45 h after
the initial transfection period (4 h). After 45 min of incubation at
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transferred to 96-well plates. The absorbance at 570 and 600 nm
(supplier indication) was measured in a SPECTRAmax PLUS 384
spectrophotometer (Molecular Devices, Union City, CA). Cell viability
(as a percentage of control cells) was calculated according to the
equation
A570−A600ð Þof treated cells
A570−A600ð Þof control cells
× 100:
2.5. Physical properties (particle size, zeta potential and colloidal
stability)
The size of the surfactant-based structures was assessed using a
Submicron Particle Size Analyzer, Beckman Coulter N4 Plus. The
colloidal suspension of the complexes was diluted with HBS, and the
particle size analysis was carried out at a scattering angle of 90° and a
temperature of 25 °C.
The zeta potential of the surfactant-based structures was mea-
sured using ZetaPals (Brookhaven Instruments Corporation, New
York, U.S.A). The measurements were performed in the aqueous
buffer HBS, at 25 °C, using disposable zeta cells and the protocol for
general purposes. The zeta potential was calculated by the device
software, using the Smoluchowski equation.
The turbidity of liposome and lipoplex dispersions, providing a
measure of their colloidal stability, was monitored as a function of
time on a SPECTRAmax PLUS 384 spectrophotometer (Molecular
Devices, Union City, CA) at a wavelength of 550 nm. The ﬁnal
concentration of lipid plus Gemini surfactant was 0.1 mM in HBS
buffer, pH 7.4. Charge ratios +/− ranging from 2/1 to 12/1 were
tested and the turbidity values were registered over time.
2.6. Fluorescence polarization measurements
The probes 1,6-diphenyl-1,3,5-hexatriene (DPH) and 3-(p-(6-
phenyl)-1,3,5-hexatrienyl)phenylpropionic acid (DPH-PA) in
dimethylformamide were injected (a few microliters) into surfac-
tant/lipid aqueous dispersions (ﬁnal surfactant/lipid concentration of
200 μM) to give a ﬁnal surfactant or surfactant plus lipid/diphenyl-
hexatriene probe molar ratio of about 200/1, as previously described
[19]. A suspension of dimyristoylphosphatidylcholine (DMPC; Avanti
Polar Lipids, Alabaster, AL) vesicles (SUV) was also prepared as
described above, at a ﬁnal concentration of 200 μM, and labelled with
DPH or DPH-PA (lipid:probe molar ratio of 200:1).
Probe addition was performed at 55 °C, a temperature above the
phase transition temperature of all the surfactant/lipid systems
tested. The mixture was incubated at room temperature, in the dark
for probe protection, for a period of 15 h to reach equilibrium. In order
to correct ﬂuorescence measurements for the contribution of light
scattering, appropriate blanks with equivalent volumes of dimethyl-
formamide were prepared, although these corrections were found to
be negligible.
The ﬂuorimetric measurements of the DPH- or DPH-PA-labelled
surfactant/lipid systems, in the absence or presence of plasmid DNA at
different cationic surfactant/DNA charge ratios, were performed in a
Perkin Elmer LS 55B ﬂuorescence spectrophotometer (Perkin Elmer,
U.S.A), equipped with polarization ﬁlters. The excitation wavelength
was set at 336 nm and the emission wavelength at 450 nm (5 nm
excitation and 6 nm emission band pass). The ﬂuorescence polariza-
tion (P) was calculated according to Shinitzky and Barenholz [20],
from the equation
P =
IΙΙ−GI⊥
IΙΙ + GI⊥
;where III and I⊥ are the intensities of the light emitted with its
polarization plan parallel and perpendicular to that of the exciting
beam, respectively. G, the instrumental grating factor, is given by the
ratio of vertically to horizontally polarized emission components
where the excitation light is polarized in the horizontal plane.
2.7. DNA protection provided by cationic surfactant/lipid formulations
and lipoplex destabilization induced by anionic lipid vesicles
A PicoGreen solution was prepared in HBS (dilution, 1:200),
according to the manufacturer's instructions (Molecular Probes,
Eugene, OR). Cationic SUV were prepared as described above, but
hydrated with HBS saline buffer. Lipoplexes containing 2 μg of pDNA,
prepared in a total volume of 200 μl of HBS, at room temperature,
were added to the PicoGreen solution and lipoplex destabilization
induced by anionic/zwitterionic lipid vesicles was evaluated. The
anionic or zwitterionic SUV were prepared, as described above, from
mixtures of dioleoylphosphatidylethanolamine (PE)/dioleoylpho-
sphatidylcholine (PC)/egg phosphatidic acid (PA) at a 2:1:1 molar
ratio; PE/PC/palmitoyloleoylphosphatidylserine (PS) at 2:1:1 molar
ratio; PE/PC/heart cardiolipin (CL)/Ca2+ at 2:1:1:1 molar ratio or PE/
PC at 1:1 molar ratio and added in a two-fold molar excess. The
ﬂuorescence of PicoGreen, directly proportional to the presence of
accessible/free DNA, wasmonitored in a Spex Fluorolog Spectrometer.
The excitation wavelength was set at 485 nm and the emission
wavelength at 520 nm (1 nm excitation and 2 nm emission band
pass).
The amount of DNA protected by cationic lipids was calculated as
follows:
PDNA = 1−
F−F100
F0−F100
where F is the ﬂuorescence measured after adding the complexes to
the PicoGreen solution, F0 is the maximum ﬂuorescence of a positive
control which accounts for 0% of DNA protection, and F100, the
minimum ﬂuorescence of a negative control which is taken as 100% of
protection. For the positive control, free DNA, in the same amount of
that associated with the complexes, was used and a PicoGreen
solution without DNA was used as the negative control.
2.8. Interaction of lipoplexes with anionic vesicles (lipid mixing)
We have conducted Förster Resonance Energy Transfer (FRET)
experiments, in order to assess the propensity for occurrence of lipid
mixing upon interaction of cationic surfactant-based vectors with
anionic vesicles. For this purpose, cationic liposomes were labelled
with 1% N-(7-nitrobenz-2-oxa-1, 3-diazol-4-yl)-Phosphatidyletha-
nolamine (NBD-PE) and 1% rhodamine-phosphatidylethanolamine
(Rho-PE) (Molecular Probes, Eugene, OR). Aliquots of both labelled
lipids in chloroform solution were added to a chloroform/methanol
solution of the cationic surfactant/lipid components. The dried lipid
ﬁlm was hydrated in a HBS saline buffer (pH 7.4) to obtain SUV. The
concentration of surfactant, or surfactant plus lipid, in the resulting
liposome suspensions was 0.1 mM. Unlabelled zwitterionic or anionic
SUV with the same composition as those used in the PicoGreen assay
(see Section 2.7) were prepared as described above and hydrated in
HBS saline buffer (pH 7.4), at a concentration of 0.4 mM. Labelled
cationic liposomes and the respective lipoplexes were transferred to
the cuvette of an LS 55B ﬂuorescence spectrophotometer (Perkin
Elmer, U.S.A) and treated with the unlabelled vesicles at 37 °C, in a 1:4
molar ratio. Fluorescence intensity was recorded at 535 nm (5 nm
band pass), as a function of time, with excitation at 470 nm (5 nm
band pass). At the concentration at which the probes were
incorporated in the liposomes (1%), Rho-PE efﬁciently suppresses
the emission of NBD-PE at 535 nm, when the excitation wavelength
Fig. 1. Effect of lipoplex composition and +/− charge ratio on luciferase gene
expression in TSA cells. Cells were covered with 0.3 ml of DMEM–HG without serum
prior to the addition of cationic liposome/DNA complexes. 14–2–14:Chol (1:1) (■) and
14–2–14:Chol:DOPE (2:1:1) ( ) liposomes were complexed with 1 μg of pCMVluc at
the indicated lipid/DNA charge ratios. After 4 h incubation, the medium was replaced
with DMEM–HG and the cells were further incubated for 48 h. The level of luciferase
gene expression was evaluated as described in Materials and methods. The data are
expressed as relative light units (RLU) of luciferase per mg of total cell protein (mean±
standard deviation obtained from triplicates), and are representative of at least three
independent experiments. Data comparisons were performed for the following paired
observations: lipoplexes at different +/− charge ratios vs the same lipoplex
formulation at the immediately precedent +/− charge ratio (*pb0.01, **pb0.005,
***pb0.001) and DOPE-containing lipoplexes vs DOPE-free lipoplexes at the same+/−
charge ratio (#pb0.01, ##pb0.001).
Fig. 2. Effect of lipoplex composition and +/− charge ratio on viability of TSA cells.
Liposomes composed of 14–2–14 (□), 14–2–14:Chol (1:1) (■) and 14–2–14:Chol:
DOPE (2:1:1) ( ) were complexed with pCMVluc at the indicated +/− charge ratios.
Values of cell viability measured by the Alamar Blue assay are expressed as a percentage
of the untreated control cells (mean±standard deviation obtained from triplicates)
and are representative of at least three independent experiments.
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distance between the donor and acceptor probes, lipid mixing
between ﬂuorescently-labelled preparations and non-labelled anion-
ic/zwitterionic vesicles is signalled by an increase of NBD-ﬂuores-
cence as a consequence of probe distribution in a larger lipid
environment. Control vesicles of 14–2–14:Chol:DOPE (2:1:1) or 14–
2–14:Chol (1:1) were labelled with 0.2 mol.% NBD-PE and 0.2 mol.%
Rh-PE, taken as the probe concentrations which are expected to be
achieved when the lipid mixing of liposomes in the sample reaches its
theoretical maximum. The ﬂuorescence intensity obtained with the
control vesicles was used for the normalization of measurements. All
the ﬂuorescence intensities were corrected for the scattered light
intensities and for the dilution factor. The percent lipid mixing was
calculated as follows:
% Lipid Mixing =
Rt−R0
R∞−R0
 
× 100 1
where, Rt, R0, and R∞ are the ﬂuorescence intensities measured at
535 nm at a given time t (Rt), prior to addition of anionic vesicles (R0),
and at inﬁnite probe dilution obtained with control vesicles (R∞),
respectively.
2.9. Statistical analysis
Data are presented as mean result±S.D. The signiﬁcance of the
results was statistically analysed by a one-way analysis of variance
(ANOVA) with Tukey's multiple comparison for pairwise comparison.
Statistical signiﬁcance was set at Pb0.05.
3. Results
3.1. Transfection efﬁciency and cytotoxicity
The gene delivery efﬁcacy of aqueous dispersions prepared from a)
the Gemini surfactant 14–2–14, b) equimolar concentrations of 14–2–
14 and cholesterol or c) 14–2–14, cholesterol and DOPE at 2:1:1molar
ratio was assessed by measuring luciferase activity. Lipoplexes were
prepared by simple addition of the plasmidDNA encoding luciferase to
the surfactant/lipid aqueous dispersion, in order to obtain+/− charge
ratios ranging from 1/1 to 12/1, which includes the theoretically
neutral combination of cationic surfactant and DNA.
Fig. 1 displays the effect of the lipid composition and +/− charge
ratio of the surfactant plus lipid-based lipoplexes on transfection in
TSA cells. These cells were chosen on the basis of their high propensity
for transfection [21]. Although essentially no gene expression was
observed with lipoplexes prepared from the neat surfactant aqueous
dispersion at +/− charge ratios ranging from 1/1 to 12/1 (data not
shown), the incorporation of helper lipids in the formulation induced
a signiﬁcant increase of the biological activity, which showed a strict
dependence on the lipoplex +/− charge ratio. Lipoplexes composed
of 14–2–14:Chol/DNA displayed the highest transfection efﬁciency at
a +/− charge ratio of 4/1, which progressively decreased with
increasing +/− charge ratio. No signiﬁcant gene expression was
observed for lipoplexes prepared at charge ratios of 1/1 or 2/1. With
DOPE-containing lipoplexes, a progressive increase of transfection
capacity was achieved with the increase of the +/− charge ratio
(from 1/1 to 8/1). However, at the highest charge ratio tested (12/1)
transfection was negligible.
The most efﬁcient formulation (14–2–14:Chol:DOPE/DNA at a +/−
charge ratio of 8/1) and the current benchmarks of transfection agents,
Lipofectamine and Fugene, were assayed in parallel to comparatively
evaluate their transfection activity in TSA cells. Although exhibiting
lower transfection efﬁciency than lipofectamine, our formulation is
signiﬁcantly more efﬁcient than Fugene in transfecting TSA cells (42%for our formulation and 25% for Fugene, with respect to lipofectamine;
data not shown).
Fig. 2 shows how the viability of TSA cells was affected upon
transfection with 14–2–14/DNA, 14–2–14:Chol/DNA or 14–2–14:
Chol:DOPE/DNA complexes at the different +/− charge ratios, as
assessed by a modiﬁed Alamar Blue assay [18]. The results were
expressed as the percentage of cell viability with respect to a control
corresponding to untreated cells. As observed, all the complexes
caused relatively low toxicity (with a minimum viability observed of
ca. 73% for 12/1 complexes) in TSA transfected cells, thus suggesting
that the different activities of transfection observed for the various
formulations are not related to any cytotoxic effect. No signiﬁcant
differences in the cytotoxicity between our formulation 14–2–14:
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Fugene were observed in these cells (data not shown).
3.2. Physical properties (zeta potential, particle size and colloidal stability)
Fig. 3 presents the zeta potential values obtained for DNA-
complexes prepared with the Gemini surfactant alone, and in
combination with cholesterol (1:1) or with cholesterol and DOPE
(2:1:1), at different +/− charge ratios. These three formulations
showed a very similar behaviour. Complexes prepared at +/− charge
ratios of 1/1 and 2/1 displayed a surface negative charge, while
positive values were obtained at the 4/1 and 8/1 charge ratios.
The mean diameter of the lipoplexes, prepared from the different
formulations at +/− charge ratios ranging from 1/1 to 8/1, and of the
corresponding particles without DNA was determined by light
scattering (Table 1). Noteworthy, the particles composed of surfactant
and DNA, especially those with higher amount of surfactant, exhibited
much larger size than the helper lipid-containing complexes, at the
same +/− charge ratio. The lipoplexes prepared from 14–2–14:Chol
and 14–2–14:Chol:DOPE dispersions showed the expected behaviour
with respect to size vs +/− charge ratio [18]. That is, at charge ratios
putatively closer to the neutrality the particle size observed is much
larger than at more extreme charge ratios, at which lipoplexes
exhibited an excess of negative and positive charges. At the +/−
charge ratios of 4/1 for the 14–2–14 plus cholesterol formulation and
2/1 for the 14–2–14:Chol:DOPE formulation, sizes of ca. 700 and
1600 nm were detected respectively, while for the remaining charge
ratios, smaller sizes (ca. 150–190 nm) were observed.
The colloidal stability of surfactant/lipid dispersions and
corresponding lipoplexes was determined by measuring the turbidity
at 550 nm, as a function of time, as illustrated in Fig. 4 for the 14–2–
14:Chol:DOPE formulation. As expected, liposomes and lipoplexes
with higher amounts of lipid showed the lowest turbidity (light
scattering) values. For all the formulations assayed, a high stability
was found within 24 h.
3.3. Characterization of the physical properties of liposomes and lipoplexes
In search of an explanation for the impressive differences in
transfection ability of surfactant vs surfactant plus helper lipid
formulations, a more extensive characterization of surfactant andFig. 3. Zeta potential of 14–2–14 (Δ) 14–2–14:Chol (■) and 14–2–14:Chol:DOPE (o)
lipoplex dispersions in HBS buffer (pH 7.4). Values were obtained in a Brookhaven Zeta
Pals, Zeta Potential Analyser, by software analysis of electrophoretic particle mobility,
fromwhich zeta potential distribution is calculated. The values represented are mean±
standard deviation, obtained for quintiplicates, in three independent experiments.surfactant plus lipid aqueous dispersions, as well as their respective
DNA-complexes, was performed using a biophysical approach. For
this purpose, we used two ﬂuorescent probes, DPH, buried in the
hydrophobic core of an amphiphilic structure, occupying the middle
of a lipid bilayer, in cases where a lamellar structure is favoured [20],
and DPH-PA, interacting with the headgroups of the amphiphilic
molecules through its charged group [22]. Fig. 5 displays the
ﬂuorescence polarization vs temperature of DPH (A) and DPH-PA
(B) embedded in preparations obtained from aqueous dispersion of
surfactant Gemini or surfactant plus cholesterol or cholesterol and
DOPE. For comparison, a typical thermotropic proﬁle of DMPC is also
represented, showing a characteristic sigmoidal curve with an abrupt
decrease of ﬂuorescence polarization within a very narrow temper-
ature range, centred at 24 °C, the transition temperature (Tm). This
behaviour, reﬂecting a phase transition from a gel or solid-ordered
phase (so) to a liquid-crystalline or liquid-disordered (ld) phase, is
observed in pure lipids as well as in some lipid mixtures, although
extended along a broader temperature range [19]. A similar
thermotropic proﬁle was obtained with the surfactant dispersion,
when DPH was used as ﬂuorescent probe (Fig. 5A). DPH ﬂuorescence
polarization derivative curves for DMPC and surfactant Gemini
preparations, determined in GraphPad Prism program (Fig. 5, inset),
allowed for the identiﬁcation of the transition temperature midpoint
(Tm) corresponding to the peak of those curves. It is noticeable the
similarity of the Tm values for the aqueous dispersions of the synthetic
lipid (DMPC) and the surfactant (14–2–14), which have in common
the length (14 carbon atoms) of the respective hydrocarbon chains.
In contrast to the surfactant dispersion, the surfactant plus lipid
formulations, namely the equimolar mixture of surfactant plus
cholesterol or the mixture of surfactant plus cholesterol and DOPE
(2:1:1), showed a distinct behaviour, exhibiting a monotonic
temperature-dependent decrease of ﬂuorescence polarization of
DPH (Fig. 5A). Fluorescence polarization of DPH-PA decreases
monotonically for all the formulations studied (Fig. 5B).
A comparison of the lipid order (taken as proportional to the P
values) for the different formulations, at temperatures above 30 °C,
reveals the lowest order values in surfactant dispersions and the
highest in the surfactant plus cholesterol (1:1) mixture; the
formulation containing surfactant, cholesterol and DOPE (2:1:1)
presented intermediate P values when compared to the other
formulations (Fig. 5 and Table 2).
The addition of DNA resulted in signiﬁcant alterations of the
physical properties of all the surfactant/lipid systems tested. As
observed, DNA induces a signiﬁcant increase of ﬂuidity, in the core of
the neat surfactant-based structure, at temperatures below 37 °C. In
contrast, at 37 °C and temperatures above, DNA promoted an increase
of lipid order, in the inner as well as in the outer regions of the
surfactant structure (Table 2). The thermotropic proﬁles of these
lipoplexes did not show any signiﬁcant dependence on the surfactant/
DNA charge ratio. For the formulation containing the surfactant and
cholesterol, an upward trend of ﬂuidity at lower temperatures (below
45 °C) and a downward trend at higher temperatures, upon the
addition of DNA, were also observed, being particularly evident in
DPH thermograms (Table 2). However, a distinct dependence of
ﬂuorescence polarization values on the surfactant/DNA charge ratio
was found. The lowest value of ﬂuorescence polarization reﬂecting the
highest level of ﬂuidity was achieved at the surfactant/DNA charge
ratio of 4/1, in the outer as well as in the inner regions of Gemini:
cholesterol structures. In contrast, the DNA-induced decrease of
ﬂuidity at 45 °C, also affecting the environments of both ﬂuorescent
probes, was more evident for the surfactant/DNA charge ratios of 2/1
and 12/1.
A very signiﬁcant effect of the presence of cholesterol in lipoplexes
is, as previously referred for liposomes, the increase of lipid order. As
illustrated in Table 2, values of ﬂuorescence polarization of DPH of
0.107 and 0.309 were obtained at 45 °C for lipoplexes at the +/−
Table 1
Particle size values, in nanometers, obtained at 25 °C for 14–2–14, 14–2–14:Chol (1:1) and 14–2–14:Chol:DOPE (2:1:1) aqueous dispersions (no DNA) and corresponding lipoplexes
at the indicated +/− charge ratios.a
Formulations No DNA +/− Charge ratios of lipoplexes
8/1 4/1 2/1 1/1
14–2–14 2737 (±270) 2168 (±467) 1694* (±321) 236 (±36) 260 (±86)
14–2–14:Chol (1:1) 139 (±28) 188 (±71) 674* (±150) 186** (±3) 172 (±8)
14–2–14:Chol:DOPE (2:1:1) 100 (±8) 173 (±36) 191* (±12) 1634** (±156) 146 (±10)
a Particle size values represent mean±standard deviation of three independent experiments. Data for each formulation at the different charge ratios were compared to those for
the same formulation at the immediately precedent +/− charge ratio (*pb0.01, **pb0.05).
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cholesterol, respectively. At the same temperature and +/− charge
ratio, P values for DPH-PA of 0.179 and 0.333 were registered for the
same structures, respectively (Table 2).
For structures prepared from a mixture of surfactant, cholesterol
and DOPE (2:1:1), the addition of DNA promoted an increase of lipid
order over the temperature range under study, in the inner as well as
in the outer regions of the lipoplex structure (Table 2). Interestingly,
at 37 °C, at which temperature transfection was performed, the
highest P values of both DPH and DPH-PA were obtained for the
lipoplexes exhibiting higher transfection competence, i.e., at a +/−
charge ratio of 8/1 (Table 2).3.4. DNA protection and release
A high level of DNA protection is an important feature of gene
carriers. However, efﬁcient gene delivery also requires that genetic
cargo will be released into the intracellular medium. Therefore, in
order to further characterize Gemini-based systems in terms of their
ability to mediate transfection, the PicoGreen ﬂuorescence assay was
used to assess both their efﬁciency to protect DNA and to promote its
release. Since PicoGreen ﬂuorescence is favoured by the presence of
double helix DNA, an increase of PicoGreen ﬂuorescence is interpreted
as an increase of DNA exposure.
The results on the level of DNA access provided by the Gemini/lipid
systems, 14–2–14, 14–2–14:Chol (1:1) and 14–2–14:Chol:DOPE
(2:1:1), at several lipid/DNA +/− charge ratios are presented in
Fig. 6. A very similar degree of DNA protection was conferred by the
different formulations, at the same +/− charge ratios. An increase
from 1/1 to 4/1 +/− charge ratio induced a signiﬁcant increase of
DNA protection for all the formulations assayed. A maximum DNAFig. 4. Colloidal stability of 14–2–14:Chol:DOPE, 2:1:1 in aqueous dispersions (▲) and
of the respective lipoplexes at +/− charge ratios of 2/1 (■), 4/1 (Δ), 8/1 (●) and 12/1
(□), monitored by turbidity measurements, at 550 nm, at different time periods. The
values represent the mean±standard deviation, obtained for triplicates, in three
independent experiments.protection was achieved at the 4/1 +/− charge ratio, this being
maintained at the +/− charge ratio of 8/1 and, predictably, for higher
values as well.
The same technique was used to assess the efﬁciency of negatively
charged or zwitterionic vesicles (see Materials and methods for
vesicle composition) to destabilize lipoplexes. Anionic lipids were
chosen as components of these vesicles based on their presence in
endosome (PA and PS) and mitochondria (CL) membranes. PE wasFig. 5. Thermogram of ﬂuorescence polarization (P) of DPH (A) and DPH-PA
(B) incorporated in 14–2–14 (▲), 14–2–14:Chol (1:1) (■), 14–2–14:Chol:DOPE
(2:1:1) (●) and DMPC (○) aqueous dispersions. The inset in A represents the
ﬂuorescence polarization derivative curves for DMPC (○) and surfactant Gemini (▲)
preparations, determined in GraphPad Prism program, allowing to identify the
transition temperature midpoint (Tm) corresponding to the peak of those curves.
Table 2
Fluorescence polarization (P) of DPH and DPH-PA, at 15, 37 and 45 °C, in 14–2–14, 14–2–14:Chol (1:1) and 14–2–14:Chol:DOPE (2:1:1) aqueous dispersions (no DNA) and
respective lipoplexes at different +/− charge ratios.a
Probe T (°C) 14–2–14 14–2–14:Chol (1:1) 14–2–14:Chol:DOPE (2:1:1)
No DNA 12/1 8/1 4/1 No DNA 12/1 4/1 2/1 No DNA 12/1 8/1 2/1
DPH 15 0.326 0.230 0.206 0.238 0.399 0.388 0.338 0.374 0.271 0.300 0.312 0.306
37 0.095 0.118 0.124 0.152 0.351 0.350 0.327 0.340 0.209 0.224 0.236 0.236
45 0.088 0.105 0.107 0.107 0.308 0.332 0.309 0.324 0.177 0.196 0.206 0.208
DPH-PA 15 0.253 0.261 0.272 0.238 0.389 0.383 0.341 0.381 0.309 0.314 0.334 0.320
37 0.186 0.194 0.205 0.191 0.351 0.352 0.339 0.352 0.261 0.274 0.290 0.271
45 0.171 0.181 0.192 0.179 0.334 0.338 0.333 0.340 0.226 0.272 0.272 0.271
a Lipoplexes of each formulation at different +/− charge ratios were prepared from the same pool of surfactant/lipid aqueous dispersion. Data shown for each formulation were
obtained in one ﬂuorescence polarization assay taken as typical of three independent experiments.
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containing vesicles (in a 1:1 molar ratio) to increase CL propensity for
HII phases, hence favouring fusion. Finally, PC was included in the
composition of all anionic lipid formulations, as a typical bilayer lipid
(DOPC). Zwitterionic vesicles of PE and PC were also used to evaluate
the importance of the anionic character of membrane lipids for DNA
release.
Lipoplexes prepared from dispersions of the Gemini surfactant 14–
2–14 did not exhibit signiﬁcant levels of DNA exposure at any of the
+/− charge ratios tested upon interaction with anionic liposomes
(Fig. 7). On the other hand, helper lipids-containing lipoplexes
exposed their DNA cargo at signiﬁcant levels for the highest +/−
charge ratios (4/1 and 8/1). For statistical purposes, results from these
experiments were compared to those obtained with the respective
formulation at the 1/1 (+/−) charge ratio, under which conditions
DNA exposure was negligible for all the formulations. The addition of
neutral vesicles (PE:PC 1:1) did not induce any signiﬁcant destabili-
zation of lipoplexes, independently of the formulation or the +/−
charge ratio.
3.5. Interaction of lipoplexes with anionic vesicles (lipid mixing)
The interactions between surfactant/lipid structures or lipoplexes
and the anionic or zwitterionic vesicles used in the previous section
were evaluated using a Förster Resonance Energy Transfer (FRET)
technique. For this purpose, the ﬂuorescent probes NBD-PE and Rho-
PE were included in the preparation of the surfactant/lipid structures
and the occurrence of lipid mixing with unlabeled anionic/zwitter-
ionic vesicles wasmonitored by an increase in NBD-PE ﬂuorescence at
535 nm (excitation at 470 nm).
As observed in Table 3, both 14–2–14:Chol and 14–2–14:Chol:
DOPE formulations, by themselves or after complexation with DNA,Fig. 6. Effect of lipoplex composition and +/− charge ratio on DNA protection as
assessed by measuring the PicoGreen ﬂuorescence. Complexes were prepared upon
incubation of (□) 14–2–14, (■) 14–2–14:Chol and ( ) 14–2–14:Chol:DOPE aqueous
dispersions with 1 μg of DNA and added to a PicoGreen solution, as described in the
Material and methods section. The results represent the mean±standard deviation
obtained from triplicates of three independent experiments. DNA protection for each
lipoplex formulation was compared to the same lipoplex formulation at the
immediately precedent +/− charge ratio (*pb0.05, **pb0.005).showed competence for undergoing signiﬁcant lipid mixing with
vesicles containing PA, PS or CL. An exception was observed with
surfactant:Chol/DNA lipoplexes at 12/1 +/− charge ratio in the
presence of PS-containing vesicles, in which case the lipid mixing
observed was ca. 13%. In contrast, the zwitterionic vesicles prepared
from the mixture PE:PC (1:1) were unable to induce high levels of
lipid mixing with the cationic liposomes and their respective
lipoplexes (maximum lipid mixing was observed for lipoplexes of
surfactant plus cholesterol at a +/− charge ratio of 4/1, ca. 32%).
Lipoplexes of both formulations displayed different susceptibility to
lipid mixing depending on the +/− charge ratio and lipid composi-
tion of the destabilizing vesicles. Regarding the transfection-compe-
tent formulations (14–2–14:Chol at the +/− charge ratio of 4/1 and
14–2–14:Chol:DOPE at the+/− charge ratio of 8/1), we observed that
both were more efﬁciently destabilized by PA- and PS-containing
vesicles than by those containing cardiolipin. On the other hand, in
comparison with 14–2–14:Chol formulation, the DOPE-containing
formulation showed higher levels of lipid mixing with any of those
vesicles.
4. Discussion
In the present work, we attempted to correlate the transfection
efﬁciency of Gemini surfactant 14–2–14-based lipoplexes or the
corresponding surfactant/lipid systems with their biophysical
properties.
In contrast with other Gemini surfactants, which are able to
transfect cells without the addition of helper lipids [14], the Gemini
14–2–14 did not exhibit transfection activity on its own (data not
shown). However, the ability of transfection was signiﬁcantly
improved, at certain surfactant/DNA charge ratios, when the Gemini
14–2–14 was used in combination with cholesterol, at a 1:1 molar
ratio, or with cholesterol and DOPE, at a 2:1:1 molar ratio.
Cholesterol and DOPE have been widely reported as suitable
helper lipids [7,8], and different hypotheses have been suggested to
explain their role in promoting gene delivery mediated by cationic
liposomes. A body of evidences have demonstrated that helper lipids
modify the aggregation morphology of the complexes by promoting
the formation of non-lamellar phases under physiologically relevant
conditions [2,6]. This property has been associated to a speciﬁc ability
of helper lipids to induce fusion of the complexes with the endosomal
membrane, facilitating DNA release into the cytoplasm [2,6]. This
assumption is based on two types of experimental evidence: ﬁrstly,
non-lamellar phases, especially those identiﬁed by 31P-NMR and
freeze–fracture electron microscopy as hexagonal II or cubic phases,
have been implicated in bilayer destabilization and fusion phenomena
[10]; secondly, lipoplexes that adopt the HII phase have shown to
strongly facilitate intracellular release of DNA and display the highest
transfection efﬁciency [23,24].
Since different levels of transfection efﬁciency were observed for
14–2–14-based lipoplex formulations, depending on the nature of
their components and the +/− cationic surfactant/DNA charge ratio,
Fig. 7. Effect of the interaction of anionic/zwitterionic liposomes with lipoplexes in terms of DNA accessibility. The complexes made of Gemini surfactant 14–2–14, 14–2–14:Chol
(1:1) and 14–2–14:Chol:DOPE (2:1:1), containing plasmid DNA (1 μg), at the indicated +/− charge ratios, were added to a PicoGreen solution (dilution: 1:200). After signal
stabilization, the anionic liposomes PE:PC:PS (2:1:1 mole ratio) (□) and PE:PC:PA (2:1:1) ( ) or the zwitterionic liposomes PE:PC:CL:Ca2+ (2:1:1:1) ( ) and PE:PC (1:1) (■) were
then injected in a two-fold excess over the cationic lipids. The ﬂuorescence signal increased and stabilized within 300 s. The results represent the mean±standard deviation
obtained from three independent experiments. Data obtained for each formulation at +/− charge ratios of 2/1, 4/1 and 8/1 were compared to those obtained with the same
formulation at the 1/1 charge ratio (*pb0.05, **pb0.005).
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mechanisms underlying the different gene carrier biological behav-
iour. Among all the factors that may be involved in the lack of
transfection efﬁciency displayed by a formulation, the potential
toxicity resulting from the presence of a speciﬁc component or from
an unfavourable mixture of components arises as one of the most
important. Our results showed that none of the tested formulations
induces a severe toxicity to TSA cells, since, for all of them, cell
viability was maintained at levels above 70%, with respect to an
untreated sample (control).
Particle size and surface charge density were also investigated
because they have revealed to be strongly related with lipoplex ability
to mediate gene delivery [25–27]. Accordingly, our results (Table 1)
showed that the formulation consisting only of the surfactant 14–2–
14, which has shown to be inefﬁcient in gene delivery, presented the
highest diameter (one order of magnitude higher when compared
with the other formulations). When complexed with DNA, at the
highest +/− charge ratios (4/1 and 8/1), the Gemini-structures still
display a large diameter (N1500 nm), and only for the lowest +/−
charge ratios (1/1 and 2/1), the size of the particles decreased to
hundreds of nanometers, a size that is within the range of dimensions
usually considered as enabling complexes to be easily internalized by
endocytic pathways [9]. This fact may be related to surfactant ability
to form elongated (wormlike) micelles instead of liposomes [28],
consistent with the non-milky aspect of their aqueous dispersions. In
fact, the efﬁciency of lipoplexes to enter the cell by the endocyticTable 3
Lipid mixing, in % of the control, obtained at 25 °C for 14–2–14:Chol (1:1) and 14–2–14:Cho
indicated in the table, in the presence of vesicles composed of a mixture of DOPE and DOPC (
phosphatidylserine (PS) and cardiolipin plus Ca2+ 1:1 (CL).a
14–2–14:Chol (1:1)
No DNA 12/1 8/1 4/1
PE:PC:PA (2:1:1) 47.64 (±0.75) 50.90 (±1.54) 39.56 (±13.05) 46.39 (±
PE:PC:PS (2:1:1) 36.92 (±9.76)* 13.07 (±7.78) 51.40 (±6.79)* 50.01 (±
PE:PC:CL (2:1:1) 40.57 (1.59)* 56.05 (±16.07)** 59.23 (±17.18)** 31.23 (±
PE:PC (1:1) 12.90 (±0.64) 20.51 (±10.33) 18.95 (±10.33) 32.13 (±
a Lipid mixing values represent mean±standard deviation of at least three independent e
to those obtained with the zwitterionic vesicles prepared from PE:PC mixture (*pb0.01, **ppathway [4], namely by clathrin- and caveolin-mediated endocytosis,
which involve the formation of coated vesicles and ﬂask-shaped
invaginations, respectively, has been shown to largely depend on
particle size [6,9]. Thus, lipoplexes composed of surfactant and DNA
seem to have an endocytosis-compatible size only under conditions
(at the lowest +/− charge ratios) where a negative zeta potential
predictably creates unfavourable interactions with cell membranes,
probably justifying the inability of these vectors to accomplish
efﬁcient gene delivery.
It is noteworthy that at the +/− charge ratios at which 14–2–14:
Chol/DNA and 14–2–14:Chol:DOPE/DNA complexes showed the
highest transfection efﬁciency (4/1 and 8/1, respectively), their sizes
are signiﬁcantly different. Whereas the DOPE-containing particles
exhibit diameters (ca. 170 nm) compatible with clathrin-mediated
endocytosis [6,9], 14–2–14:Chol/DNA particles have an average
diameter of 600 nm (Table 1), thus being more prone to be
internalized by macropinocytosis or endocytosed via caveolae.
When reaching caveosomes, the cholesterol-containing lipoplexes
may be directly transported to the Golgi and/or endoplasmic
reticulum (ER), circumventing lysosomal degradation [4]. On the
other hand, due to the topological relation of ER and mitochondria,
the Gemini–cholesterol formulation may also constitute a good
candidate to deliver genetic cargo into mitochondria. Studies are
currently in progress to address this possibility.
The surface charge density of the complexes, measured in terms of
zeta potential, has also been reported as a critical factor for lipoplexl:DOPE (2:1:1) aqueous dispersions (no DNA) and lipoplexes at the +/− charge ratios
PE:PC) or this mixture and one of the following phospholipids: phosphatidic acid (PA),
14–2–14:Chol:DOPE (2:1:1)
No DNA 12/1 8/1 4/1
12.69) 72.24 (±6.14) 72.83 (±2.10)* 78.61 (±5.31) 43.15 (±11.87)
6.11)** 54.27 (±9.88)** 78.81 (±0.15) 62.60 (±11.41)* 31.08 (±11.93)
7.98) 41.24 (±2.31)* 33.35 (±4.36) 44.77 (±14.45)** 48.69 (±14.63)
17.51) 8.54 (±5.09) 11.09 (±4.77) 6.76 (±4.38) 20.15 (±13.27)
xperiments. Data for the lipid mixing with the different anionic vesicles were compared
b0.05).
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preventing interactions with serum proteins and resisting to nuclease
degradation in vivo [2,25]. All the complexes prepared at 1/1 and 2/1
+/− charge ratios displayed negative zeta potentials, justifying their
inability for gene delivery. Consistently, the transfection-competent
complexes showed positive zeta potentials, enabling their interaction
with the negative cell surface.
Another important lipoplex feature, shared by all the formulations,
irrespectively of the lipid composition and charge ratio, is their
capacity to preserve the original size (colloidal stability) over 24 h.
In order to explainwhy the formulations used in thiswork displayed
different transfection activities, an extensive characterization of their
biophysical properties was carried out. Fluidity is the physical
parameter most frequently assessed in lipid-containing systems to
characterize and evaluate the extent of lipid–foreign molecule interac-
tions [29,30]. However, lipid bilayers (and lipoplexes) are highly
anisotropic systems, and, therefore, the meaning of the term ﬂuidity
applied to these structures differs from the physical concept of ﬂuidity,
the latter being only applicable to isotropicmedia. In thiswork, we used
ﬂuorescent ﬂuidity probes and the ﬂuorescence polarization to
characterize the physical properties of the Gemini-containing lipid
structures, associated or not with DNA at different +/− charge ratios.
The rotational diffusion of the probes, depending on the degree of the
molecular packing (order) in the surfactant/lipid system, results in
depolarization of ﬂuorescence. Therefore, the term ﬂuidity is used here
as being inversely proportional to the degree of ﬂuorescence polariza-
tion of DPH/DPH-PA probes. This technique, which is very sensitive and
reproducible, has been extensively used to obtain a detailed picture of
physical phenomena at amolecular level in the interior of a lipid bilayer
[19,29,30]. Additionally, by using different ﬂuorescent probes, the
technique offers the possibility of detecting alterations of molecular
order at different depths of the surfactant/lipid structure [20,22].
As expected, the range of values within which ﬂuorescence
polarization of DPH and DPH-PA varies along the transition of DMPC
(from 0.34 to 0.15 and 0.40 to 0.24, respectively), reﬂects an increase
of disorder from the surface to the core of the lipid bilayer, consistent
with data provided by this [31] and other spectroscopic techniques,
namely EPR and NMR [32]. Interestingly, for the surfactant plus lipid
systems, prior or following DNA complexation (Table 2), the
ﬂuorescence polarization of DPH-PA reaches higher values than
those reported by DPH at the same temperature, with few exceptions.
This is a clear indication that DPH and DPH-PA have been efﬁciently
incorporated in all the formulations, in distinct lipid environments.
Establishing a parallel to what has been reported in lipid bilayers
[29,30], the ﬂuorescent probes DPH and DPH-PA are expected to
monitor the structural order of the lipid/DNA systems at two distinct
levels: in the hydrophobic core, i.e., far from the aqueous medium, the
preferred DPH environment [20], and closer to the water/lipid
interface, where electrostatic interactions dominate and DPH-PA
prefers to be located [22].
Fig. 5 evidenced two other important aspects, related with the
inﬂuence of cholesterol incorporation in the surfactant system: a) the
disappearance of the phase transition, found in both cholesterol-
containing systems, and b) the induction of a higher level of lipid
order, in the system at which DOPE was not added. These aspects
may reﬂect a cholesterol-induced increase of the packing of
surfactant hydrocarbon chains, producing more compact arrange-
ments, provided with much less void volume in its interior, in
agreement with classical reports of cholesterol effects on lipid
structures [11,12].
DNA addition to all surfactant-containing aqueous dispersions also
showed important physical effects. Because of the DNA electrostatic
interaction with the positive charges of the surfactant Gemini, a
decrease of the repulsive lateral pressure at the level of surfactant/
lipid polar groups could induce a tighter packing of the hydrophobic
chains, at high temperatures. Thus, with few exceptions, an increaseof the ﬂuorescence polarization of DPH-PA, as well as DPH, was
noticed at 37 and 45 °C, in the presence of DNA (Table 2). In the case of
the surfactant formulation, DNA complexation could impair the
formation of a highly ordered phase at low temperatures, justifying
the DNA-induced decrease of ﬂuorescence polarization of DPH and, at
a lesser extent, of DPH-PA, at 15 °C (Table 2). Interestingly, at this
temperature, a higher level of order was detected in the hydrophobic
core of the surfactant structure than at the outer regions. This
observation is, as mentioned above, opposed to what is usually found
in a typical bilayer, and may reﬂect a micellar structure adopted by
surfactant molecules upon hydration [28], according to what has been
reported for other Gemini surfactants [33,34]. Under these conditions,
due to steric constraints, it is likely that the repulsive interactions of
surfactant cationic groups create a more relaxed structure in the
proximity of the micelle surface, the van der Waals interactions being
progressively more favoured towards the centre of the micelle. Upon
DNA complexation, the surfactant aggregates undergo rearrangement
and, similarly to surfactant plus lipid structures, show a typical
gradient of ﬂuidity, increasing from the outer to the more hydropho-
bic inner regions of the complex structure.
The physical properties of cholesterol-containing lipoplexes
display a notable dependence on the surfactant/DNA charge ratio.
Curiously, at 37 °C, temperature at which transfection was carried
out, the ﬂuorescence polarization of DPH and DPH-PA in surfactant
plus cholesterol (1:1)/DNA complexes, featured by a high level of
order, reaches the lowest values at the 4/1 +/− charge ratio. On
the other hand, in DNA complexes containing the surfactant,
cholesterol and DOPE (2:1:1), which show a more disordered
structure, the ﬂuorescence polarization of both probes attains the
highest values at a +/− charge ratio of 8/1 (Table 2). Thus, the
values of lipid order in both lipoplex formulations become closer to
each other at +/− charge ratios at which lipoplexes exhibited the
highest competence for transfection. This fact suggests the
existence of a putative range of the surfactant/lipid hydrocarbon
chain order within which the formulations present the highest
ability for gene delivery.
A very high degree of DNA protection (Fig. 6) was achieved for all
the formulations with an excess of surface positive charges (+/−
charge ratios above 2/1 as assessed by zeta potential measurements).
As expected, both formulations with the highest transfection activity,
14–2–14:Chol at the 4/1+/− charge ratio and 14–2–14:Chol:DOPE at
the 8/1 +/− charge ratio, are included in the group of those which
providemaximumDNA protection. The surfactant per se seems also to
be able to efﬁciently protect DNA. This fact is consistent with other
reports showing that micellar as well as vesicular aggregates can
confer high protection to DNA [8]. As expected, such protection was
negligible when the cationic amphiphile–DNA complexes were put in
the presence of anionic lipid vesicular aggregates (Fig. 7). The purpose
of this study was to mimic the situation of DNA release into the cell. In
fact, a central step in cationic lipid-mediated transfection is the
endosome escape of DNA into the cytoplasm [2,4,35], or into the
mitochondrial matrix [5]. As pointed out by some authors [2,4–
6,35,36], this event may be preceded by interaction and neutralization
of cationic lipids by the endosomal/mitochondrial anionic lipids. As
clearly shown in Fig. 7, the highest values of PicoGreen ﬂuorescence
were observed for both formulations containing helper lipids, at the
highest +/− charge ratios. At +/− charge ratios of 1/1 or 2/1, all the
formulations were not or were only slightly destabilized by the
addition of anionic vesicles. At these +/− charge ratios, lipoplexes
displayed a negative zeta potential, as shown in Fig. 3, hence
efﬁciently repelling anionic lipid vesicles. In contrast to the other
formulations, Gemini surfactant/DNA complexes showed a limited
ability to expose their genetic cargo upon contact with anionic
vesicles, even at the highest +/− charge ratios, under which
conditions a favourable interaction with negatively charged phos-
pholipids would be predictable. Therefore, the surfactant structure,
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tibility for destabilization, justifying its incompetence for gene
delivery. In fact, although DNA protection conferred by the gene
carriers is of extreme importance to prevent its degradation by the
action of nucleases [2,25,35], an excessive condensation of DNA by the
cationic lipids may be an obstacle to its release into the intracellular
medium. As opposed to anionic lipid-containing mixtures, those
containing only zwitterionic lipids showed low ability to compromise
DNA protection conferred by all the cationic surfactant/lipid
formulations.
To further characterize the interaction of surfactant/lipid carriers
with membrane-mimicking vesicles, the propensity for lipid mixing
when cationic lipids were confronted with anionic phospholipid-
containing vesicles was investigated using a Förster Resonance Energy
Transfer (FRET) assay.
Both surfactant/lipiddispersions and respective lipoplexeswere able
to undergo lipid mixing with PA-, PS- and CL-containing vesicles, and
even with PE:PC vesicles, although at a signiﬁcantly lower level. The
competence of these formulations for lipid exchange with membranes
of different lipid composition and net charge (negative for PA- and PS-
containing membranes and neutral for CL+Ca2+-containing mem-
branes and the mixture PE and PC) suggests a high propensity for DNA
release upon membrane interaction. From the results obtained from
PicoGreen and FRET experiments, we may suggest that, at the highest
+/− charge ratios tested, DNA exposure detected by the PicoGreen
assay can, apparently, be attributed to the occurrence of a high level of
interaction involving the cationic systems and anionic vesicles,
accompanied by lipid exchange and membrane fusion.
The endosomal release of DNA from different lipid-based gene
vectors [33,35,37] has been proposed as involving the phospholipid
PS. Apparently, PS undergoes ﬂip-ﬂop from the outer to the inner
leaﬂet, following interaction of lipoplexes with the endosome
membrane, resulting in DNA dissociation and formation of ion-pairs
between PS and the cationic lipids [6,9,35]. PS access to lipoplexes has
been proposed as being favoured by the presence of DOPE/cationic
lipid domains adopting inverted hexagonal phases. Our data indicate
that endosomes and mitochondria are potentially good targets for the
studied formulations, since they demonstrate a signiﬁcant level of
lipid mixing with PS- as well as with CL-containing vesicles. It is
important to note that mitochondria targeting represents a recent
focus of interest for gene therapy applications [5].
5. Conclusions
The Gemini surfactant 14–2–14 successfully replaces other
cationic lipids in gene carrier formulations, offering a high level of
DNA protection. However, Gemini-based gene delivery systems need
to be assisted by helper lipids to exhibit competence for transfection.
The incorporation of cholesterol or cholesterol and DOPE in the
surfactant system promoted signiﬁcant structural alterations and
higher susceptibility for DNA exposure in the presence of anionic
lipids.
Since cholesterol- and cholesterol:DOPE-containing lipoplexes
show very different average sizes (600 nm and 170 nm, respectively)
at the +/− charge ratios they are most efﬁcient (4/1 and 8/1,
respectively) in transfection, it is likely that they use distinct
pathways for cell internalization. This fact will be taken into account
in future work, when considering different cell and intracellular
targets for gene delivery.
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